Pfizer Submits Data for COVID-19 Vaccine Use in Younger Kids
Pfizer Inc and BioNTech SE on Tuesday submitted initial trial data for their COVID-19 vaccine in 5-11 year olds and said they would make a formal request to U.S. regulators for emergency use in the coming weeks.
Originally appeared on Newsmax Read More
BREAKING NEWS
- Saudi Arabia’s Massive Futuristic Vanity Projects Falter Amid Gaza War
- Luxury DC Apartment Building Replaces Front Desk Staff With Amazon Lockers, Sparking Tenant Protest
- Judge Shoots Down Effort To Identify FBI, Undercover Police On Jan. 6
- How Hard Is It To Get Into An Ivy League School?
- Taxing Unrealized Gains Would Obliterate The U.S. Economy
- Judge Cannon Unseals Docs Alleging Jack Smith’s Lead Prosecutor Threatened Trump Valet Attorney and Tried to Bribe Him in Exchange For Client’s Testimony Against Trump
- Supreme Court Justice Clarence Thomas Discusses Operation Mongoose in Presidential Immunity Arguments (VIDEO)
- Victor Reacts: $95B to Foreign Countries- America Last (VIDEO)
- US Navy Converting Oil Rigs Into Active Missile Launch Stations with Five Times the Capacity of a Destroyer
- NFL Pro Bowler Humbles Mouthy High Schooler with a Simple Question
Leave a Reply